Markerless, sequential or multiplexed knockout strains of Vibrio natriegens built using CRISPR-Cas9 and natural transformation.
Leverage Vibrio natriegens' rapid doubling time and natural competence for streamlined construction of defined knockout strains, supporting metabolic engineering and synthetic biology projects from design to validated clones.
We combine CRISPR-Cas9 with Vibrio natriegens' natural transformation pathway to achieve precise, scarless gene deletions without antibiotic resistance markers. The workflow is tailored to your target genes and can be extended to multiple rounds or simultaneous multiplexed edits.
Our bioinformatics team designs single or multiplex gRNAs targeting your genes of interest, evaluates off-target potential, and assembles Cas9-expressing plasmids with corresponding repair templates.
V. natriegens cells are transformed with the editing plasmids plus repair templates via natural transformation. Edited clones are selected by transient resistance and screened by colony PCR for the desired deletion.
Sequential rounds or co-transformation of multiple gRNAs enable deletion of two or more genes in the same strain, depending on project scope and target compatibility.
Editing leaves no exogenous antibiotic marker in the genome, suitable for metabolic engineering where marker-free strains are required for downstream applications.
Every candidate clone is verified by PCR spanning the deletion junctions and Sanger sequencing to confirm the intended knockout sequence.
Each project delivers a set of verified clonal strains and supporting documentation for seamless integration into your research pipeline.
Each project is scoped in collaboration with our scientific team to match your specific target list, timeline, and quality requirements.
| Parameter | Typical project scope |
|---|---|
| Target Organism | Vibrio natriegens (wild-type or derivative strains; custom strains by arrangement) |
| Editing Method | CRISPR-Cas9 with natural transformation (NT-CRISPR); markerless deletion |
| Number of Genes | 1–5+ genes; sequential or multiplexed depending on gRNA compatibility |
| Design Support | In silico gRNA design and off-target assessment included prior to construction |
| Verification | PCR genotyping and Sanger sequencing of each deletion junction |
| Quality Control | Confirmation of intended deletion; no wild-type contamination; glycerol stock viability check |
| Technical Support | Named scientific contact at project start; milestone review calls; email response within 1 business day |
A streamlined five‑step process ensures transparent communication and high‑quality results at every stage.
Our team reviews your target gene list and strain background, performs in silico gRNA design, and proposes an editing strategy. You approve the design before construction begins.
We build the Cas9‑expressing vector and gRNA expression cassette(s), along with linear repair templates for homologous recombination. All constructs are sequence‑verified.
V. natriegens is transformed with editing plasmids and repair templates. Transformants are screened by colony PCR to identify clones carrying the desired deletion. Multiple rounds are performed for sequential multi‑gene knockout.
Positive candidates are purified to clonal populations. Genomic DNA is extracted, and deletion junctions are amplified and Sanger‑sequenced. Only clones with confirmed deletion proceed to final delivery.
Verified clones are prepared as glycerol stocks, labelled, and shipped with a project report including methods, QC, and datasets including all design files, PCR images, sequencing chromatograms, and QC results.
Vibrio natriegens is valued for its exceptionally fast growth and natural competence, making it an attractive host for metabolic engineering and synthetic biology.
Knock out competing metabolic pathways or byproduct‑forming genes to redirect flux toward a target product (e.g., value‑added chemicals, biofuels).
Investigate gene essentiality and phenotype contribution by systematically deleting candidate genes and assessing growth, stress response, or metabolic changes.
Simplify the genome or remove problematic elements (e.g., prophages, non‑essential genes) to create a more predictable and stable synthetic biology chassis.
Find quick answers about scope, timeline, QC, and deliverables below.
Projects typically cover 1–5 target genes, depending on their genomic arrangement and gRNA compatibility. Sequential rounds allow additional deletions, while multiplexed co‑transformation can combine 2–3 genes in one step if design constraints permit. Final scope is determined during consultation.
Yes. Our NT‑CRISPR workflow uses transient selection to enrich for edited cells, but the final strain carries no antibiotic resistance marker in its genome. The deletion is precisely scarless, limited to the intended target sequence.
All candidate clones are confirmed by PCR spanning the deletion region and Sanger sequencing to investigate exact edit. We deliver only clones with confirmed deletion. Glycerol stocks are tested for viability. Off‑target analysis can be included as an optional add‑on, scoped per project.
We can accept custom strains or those previously engineered, subject to compatibility with our transformation protocol. Please discuss your strain background during the consultation so we can assess feasibility and any required modifications.
Get a customized quote for your Vibrio natriegens Multi-Gene Knockout Strain Construction project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.